// App-Quantinova.ai

PB1766 : PROGNOSTIC SIGNIFICANCE OF ACTIVIN A IN ADULT EGYPTIAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA.

Researchers

Presenter

  • Mohamed Azzazi

Principal Investigators

  • Hany Hegab

  • Amro EL-Ghammaz

  • Verna Shawky

  • Heba Hafez

  • Reham Helal

Medical Centers

  • Hematology and Bone marrow transplantation, internal medicine,Faculty of Medicine , Ain Shams University,Cairo,Египет

  • Hematology and Bone marrow transplantation, internal medicine,Faculty of Medicine , Ain Shams University,Cairo,Египет

  • Hematology and Bone marrow transplantation, internal medicine,Faculty of Medicine , Ain Shams University,Cairo,Египет

  • Hematology and Bone marrow transplantation, internal medicine,Faculty of Medicine , Ain Shams University,Cairo,Египет

  • Hematology and Bone marrow transplantation, internal medicine,Faculty of Medicine , Ain Shams University,Cairo,Египет

  • Hematology and Bone marrow transplantation, internal medicine,Faculty of Medicine , Ain Shams University,Cairo,Египет

  • Hematology and Bone marrow transplantation, internal medicine,Faculty of Medicine , Ain Shams University,Cairo,Египет

  • Hematology and Bone marrow transplantation, internal medicine,Faculty of Medicine , Ain Shams University,Cairo,Египет

  • Hematology and Bone marrow transplantation, internal medicine,Faculty of Medicine , Ain Shams University,Cairo,Египет

Locations

  • United States

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Activin A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved